InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001773751-25-000032 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-04 2025-01-31 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $35.22 -100.0K 27.9K -78% -$3.52M
D 2025-02-04 2025-01-31 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $2.43 +100.0K 127.9K +358% +$243.0K
D 2025-02-04 2025-01-31 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -100.0K 1.41M -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-01-31 S D 100,000 $35.22 27,918 D — — (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.00 - $35.48. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Class A Common Stock 2025-01-31 M A 100,000 $2.43 127,918 D — —
3 Derivative Stock Option (right to buy) 2025-01-31 M D 100,000 $0.00 1,406,401 D $2.43 · — to 2030-06-16 100,000 Class A Common Stock (F3) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.